Gene · 1846
Papers1,689
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,689
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Whole blood coagulation in an ex vivo thrombus is sufficient to induce clot neutrophils to adopt a myeloid-derived suppressor cell signature and shed soluble Lox-1. | J Thromb Haemost | 2024 | 38135253 | PubTator, text mining | PubMed |
| ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanoma. | Oncogene | 2024 | 38066089 | PubTator, text mining | PubMed |
| DOCK1 insufficiency disrupts trophoblast function and pregnancy outcomes via DUSP4-ERK pathway. | Life Sci Alliance | 2024 | 37967942 | PubTator, text mining | PubMed |
| Correlation Analysis between Hypogonadal Symptoms and Changes in Body Composition and Physical Fitness after Testosterone Treatment in Men with Testosterone Deficiency. | World J Mens Health | 2024 | 37118963 | PubTator, text mining | PubMed |
| Mesothelin expression correlates with elevated inhibitory immune activity in patients with colorectal cancer. | Res Sq | 2023 | 38234761 | PubTator, text mining | PubMed |
| Single cell RNA-sequencing profiling to improve the translation between human IBD and in vivo models. | Front Immunol | 2023 | 38179052 | PubTator, text mining | PubMed |
| Dual-Specificity Phosphatases in Regulation of Tumor-Associated Macrophage Activity. | Int J Mol Sci | 2023 | 38139370 | PubTator, text mining | PubMed |
| Single-cell characterization of human GBM reveals regional differences in tumor-infiltrating leukocyte activation. | Elife | 2023 | 38127790 | PubTator, text mining | PubMed |
| Single-cell and spatial transcriptomics reveal POSTN+ cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer. | Clin Transl Med | 2023 | 38115703 | PubTator, text mining | PubMed |
| Deciphering the immune landscape of head and neck squamous cell carcinoma: A single-cell transcriptomic analysis of regulatory T cell responses to PD-1 blockade therapy. | PLoS One | 2023 | 38096229 | PubTator, text mining | PubMed |
| Genome-wide CRISPR/Cas9 screening for drug resistance in tumors. | Front Pharmacol | 2023 | 38084101 | PubTator, text mining | PubMed |
| Research progress on the immune microenvironment and immunotherapy in gastric cancer. | Front Immunol | 2023 | 38077373 | PubTator, text mining | PubMed |
| ARID1A loss activates MAPK signaling via DUSP4 downregulation. | J Biomed Sci | 2023 | 38071325 | PubTator, text mining | PubMed |
| Early cellular and molecular signatures correlate with severity of West Nile virus infection. | iScience | 2023 | 38047068 | PubTator, text mining | PubMed |
| CAR-modified Cellular Therapies in Chronic Lymphocytic Leukemia: Is the Uphill Road Getting Less Steep? | Hemasphere | 2023 | 38044959 | PubTator, text mining | PubMed |
| A guide to ERK dynamics, part 2: downstream decoding. | Biochem J | 2023 | 38038975 | PubTator, text mining | PubMed |
| Transcriptional impact of EGFR activation in human female vascular smooth muscle cells. | iScience | 2023 | 38026216 | PubTator, text mining | PubMed |
| Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy. | J Immunol Res | 2023 | 38023616 | PubTator, text mining | PubMed |
| Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study. | Cell Rep Med | 2023 | 38016482 | PubTator, text mining | PubMed |
| Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents. | Nutrients | 2023 | 38004113 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1846/papers?page=5